PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Fusidic acid - Bacterial infection
PAD Profile : Fusidic acid - Bacterial infection
Keywords :
antibiotic, antibacterial
Brand Names Include :
Fucidin
Traffic Light Status
Status 1 of 1.
Status :
Blue
Important
Formulations :
- Suspension
- Tablets
Important Information :
Follow local guidelines on the use of antimicrobials. Use in primary care when indicated by microbiology eg on culture results. Note - licensed products are being discontinued in 2025.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
- Cefaclor
- Amoxicillin
- Azithromycin
- Benzylpenicillin sodium (Penicillin G)
- Cefalexin
- Cefotaxime sodium
- Ceftriaxone sodium
- Ciprofloxacin
- Clarithromycin
- Co-trimoxazole(Trimethoprim/sulfamethoxazole)
- Doxycycline hyclate
- Erythromycin
- Flucloxacillin sodium
- Levofloxacin
- Metronidazole
- Nitrofurantoin
- Phenoxymethylpenicillin (Penicillin V)
- Trimethoprim
- Amikacin
- Aztreonam
- Cefepime
- Cefixime
- Ceftazidime pentahydrate
- Cefuroxime sodium
- Chloramphenicol
- Dalbavancin hydrochloride
- Dapsone
- Daptomycin
- Demeclocycline hydrochloride
- Ertapenem sodium
- Gentamicin sulfate
- Imipenem with cilastatin
- Meropenem
- Moxifloxacin
- Norfloxacin
- Ofloxacin
- Piperacillin sodium/tazobactam sodium
- Rifabutin
- Sodium fusidate
- Streptomycin
- Sulfadiazine
- Teicoplanin
- Temocillin sodium
- Tigecycline
- Tinidazole
- Vancomycin hydrochloride
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
05 February 2025
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
Fusidic acid (Fucidin) 250mg tablets and 250mg/5ml oral suspension are being discontinued in Jan 2025 and Jun 2025 respectively.
The Specialist Pharmacy Service (SPS) have issued advice on appropriate actions and alternative, unlicensed preparations: https://www.sps.nhs.uk/shortages/discontinuation-of-sodium-fusidate-fucidin-250mg-tablets-and-fusidic-acid-fucidin-250mg-5ml-oral-suspension/
01 May 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
05. Infections
05.01.07. Some other antibacterials